Elicio Therapeutics, Inc. (ELTX)
1.50
-0.09
(-5.66%)
USD |
NASDAQ |
Nov 19, 16:00
1.485
-0.02
(-1.00%)
After-Hours: 20:00
Elicio Therapeutics Price to Book Value : 2.252 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.252 |
| November 18, 2026 | 2.388 |
| November 17, 2026 | 2.147 |
| November 16, 2026 | 2.222 |
| November 13, 2026 | 2.252 |
| November 12, 2026 | 2.343 |
| November 11, 2026 | 2.448 |
| November 10, 2026 | 2.418 |
| November 09, 2026 | 2.470 |
| November 06, 2026 | 2.268 |
| November 05, 2026 | 2.102 |
| November 04, 2026 | 2.343 |
| November 03, 2026 | 2.282 |
| November 02, 2026 | 2.388 |
| October 30, 2026 | 2.523 |
| October 29, 2026 | 2.628 |
| October 28, 2026 | 2.778 |
| October 27, 2026 | 2.748 |
| October 26, 2026 | 2.553 |
| October 23, 2026 | 2.853 |
| October 22, 2026 | 2.913 |
| October 21, 2026 | 2.508 |
| October 20, 2026 | 2.358 |
| October 19, 2026 | 2.328 |
| October 16, 2026 | 2.343 |
| Date | Value |
|---|---|
| October 15, 2026 | 2.673 |
| October 14, 2026 | 2.688 |
| October 13, 2026 | 2.658 |
| October 12, 2026 | 2.823 |
| October 09, 2026 | 2.838 |
| October 08, 2026 | 2.718 |
| October 07, 2026 | 2.778 |
| October 06, 2026 | 2.823 |
| October 05, 2026 | 2.883 |
| October 02, 2026 | 2.883 |
| October 01, 2026 | 2.883 |
| September 30, 2026 | 2.733 |
| September 29, 2026 | 5.077 |
| September 28, 2026 | 5.105 |
| September 25, 2026 | 5.077 |
| September 24, 2026 | 5.188 |
| September 23, 2026 | 5.160 |
| September 22, 2026 | 5.160 |
| September 21, 2026 | 5.271 |
| September 18, 2026 | 5.215 |
| September 17, 2026 | 5.146 |
| September 16, 2026 | 4.884 |
| September 15, 2026 | 5.491 |
| September 14, 2026 | 5.519 |
| September 11, 2026 | 5.657 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lineage Cell Therapeutics, Inc. | 3.092 |
| Armata Pharmaceuticals, Inc. | -- |
| Voyager Therapeutics, Inc. | 0.7409 |
| Black Diamond Therapeutics, Inc. | 0.9069 |
| Invivyd, Inc. | 0.876 |
Price to Book Value Related Metrics
| Price | 1.50 |
| Earnings Yield | -120.9% |
| Market Cap | 42.46M |